{"title": "PDF", "author": "PDF", "url": "www.dgra.de/media/pdf/studium/im_studium/downloads_und_merkblaetter/2019_MDRA_Abkuerzungen.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "1 \n \n \n \n \n \n \n \n \n \n \nAbk\u00fcrzungsverzeichnis \nList of Abbreviations \n \n \nf\u00fcr den weiterbildenden Masterstudiengang \n \n \n\u201eDrug Regulatory Affairs\u201d \n \n \n \n \n \nStand: September 2019 2 \n  \nShort Cut Complete Name  Additional Information  \nAADA Abbreviated Antibiotics Drug Applications   \nAAS  Atomabsorptionsspektroskopie   \nABDA  Bundesvereinigung Deutscher \nApothekerverb\u00e4nde   \nABDATA  Gesch\u00e4ftsbereich der Apothekenverb\u00e4nde   \nABI  Amtsblatt der Europ\u00e4ischen Gemeinschaft   \nABPI  The Association of the British Pharmaceutical  \nIndustry   \nACCSQ  Consultative Committee for Standards and \nQuality   \nACE  Angiotensin Converting Enzyme   \nACSoMP  Advisory Committee on Safety of Medicinal \nProducts  Beratungskommitte f\u00fcr die \nWHO  \nACTA  Anti Counterfeiting Trade Agreement  Handelsa bkommen zum Schutz \nvor Produktf\u00e4lschungen  \nADBE  absorption, distribution, biotransformation, \nexcretion   \nADEC  Australian Drug Evaluation Committee   \nADI  /g1uthorizat daily intake   \nADM Administrative Information  \nADME  absorption, distribution, metabolism, excreti on  (of a compound) \nADP  Adenosin-Diphosphat   \nADR  Adverse Drug Reaction Noxious/unintended \nresponse   \nADRAC  Adverse Drug Reactions Advisory Committee  U nterkommitee von ADEC \nADKA  Arbeitsgemeinschaft Deutscher \nKrankenhausapotheker   \nADROIT ADRs  Online Information Tracking   \n\u00c4A  \u00c4nderungsanzeige   \nAE  Adverse Event Untoward medical occurrence   \nAECB  acute exacerbation of chronic bronchitis   \nAEFI  adverse events following immunization   \nAEGIS ADROIT Electronically Generated Information S ervice   \nAEPAR  Asocaci\u00f3n Espanola de Profesionales de \nActividades de Registro   \nAERS  Adverse Event Reporting System   \nAESGP  Assocaiation Europ\u00e9enne des Specialit\u00e9s \nPharmaceutiques Grand Public   \nAEUV Vertrag \u00fcber die Arbeitsweise der \nEurop\u00e4ischen Union  \nAFAR  Association Fran\u00e7aise des Affaires \nR\u00e9glementaires   \nAfL\u00dc Amt f\u00fcr Lebensmittel\u00fcberwachung  \nAFSSAPS  L\u2019Agence Fran\u00e7aise de Securit\u00e9 Sanitaire d e \nProduits de Sant\u00e9 Regulatory Authority in France \nAg Antigen  \nAGES  Agentur f\u00fcr Gesundheit und \nErn\u00e4hrungssicherheit  \u00d6sterreichische \nZulassungsbeh\u00f6rde \nAGF  Alleingesch\u00e4ftsf\u00fchrer   \nAGLMB  Arbeitsgemeinschaft der leitenden \nMedizinalbeamtinnen und \u2013beamten der \nL\u00e4nder   3 \n Short Cut Complete Name  Additional Information  \nAHI  Animal Health Institute   \nAHP Analytic Hierarchy Process  \nAICRC  Association of Independent Clinical Research  \nContractors   \nAIDS  Acquired Immune Deficiency Syndrome   \nAIM  active ingredient manufacturer   \nAIMDD Active Implantable Medical Devices Directive   \nAIVR  Accelerated Idioventricular Rhythm   \nAkd\u00c4  Arzneimittelkommission der deutschen \n\u00c4rzteschaft   \nAL Akzeptanzlimit  \nAL Approvable Letter (Schweiz) \nALADI  Asociaci\u00f3n Latinoamericana de Integraci\u00f3n  L atin American Integration \nAssociation \nALARP  as low as reasonably practicable   \nALAT alanine aminotransferase Synonym: ALT \nALIFAR  Asociaci\u00f3n Latinoamericana de Industrias \nFarmac\u00e9uticas Latin American association of \nthe generic industry   \nALT  alanine aminotransferase  Synonym: ALAT \nALV  Arzneiliefervertrag   \nAM  Arzneimittel   \nAMA  American Medical Association   \nAMG  Arzneimittelgesetz  German Drug Law  \nAMG-AV  Arzneimittelgesetz-Anzeigeverordnung   \nAMG-EV AMG- Einreichungsverordnung   \nAMED  Allied and Alternative Medicine   \nAMES  Verfahren zur Identifizierung von Mutagenen \nnach dem Amerikaner Bruce Ames   \nAMIS II  Arzneimittel-Informationssystem (BfArM)   \nAMK  Arzneimittelkommission der Deutschen \n\u00c4rzteschaft   \nAMM  Autorisation de Mise sur le March\u00e9   \nAMNOG  Arzneimittelmarktneuordnungsgesetz   \nAMR  Arzneimittelreport   \nAMR  Arzneimittelrichtlinie des G-BA   \nAMRadV  Verordnung \u00fcber radioaktive oder mit \nionisierenden Strahlen behandelte \nArzneimittel   \nAMRL  Arzneimittel-Richtlinien des GBA   \nAMTS  Arzneimitteltherapiesicherheit   \nAMWHV  Arzneimittel-und \nWirkstoffherstellungsverordnung  Ersetzt die bisherige \nPharmBetrV  \nANDA  Abbreviated New Drug Application Approval \nprocess for generics  \n (USA)  \nANMAT  Administraci\u00f3n Nacional de Medicamentos, \nAlimentos y Tecnologica M\u00e9dica Argentinische \nZulassungsbeh\u00f6rde National \nAdministration for Medicines, \nfood and Medical Technology \nANOVA  Analysis of Variance   \nANSI  American National Standards Institute   4 \n Short Cut Complete Name  Additional Information  \nANVISA  Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria  N ationale Beh\u00f6rde f\u00fcr \nGesundheits\u00fcberwachung in \nBrasilien (National Health \nSurveillance Agency)  \nANZTPA  Australia New Zealand Therapeutic Products \nAuthority  Gemeinsame \nZulassungsbeh\u00f6rde f\u00fcr \nAustralien und Neuseeland  \nAOK  Allgemeine Ortskrankenkasse   \naP acellular pertussis pertussis vaccines \nAP  Anstaltspackung   \nAP Alkaline Phosphatase  \nApBetrO  Apothekenbetriebsverordnung   \nAPC  adenomatous polyposis coli   \nAPEC Asia-Pacific Economic  Cooperation  \nAPI  Active Pharmaceutical Ingredient   \nAPNIC  Asia Pacific Network Information Centre   \nApoBetrO  Apothekenbetriebsordnung   \nApoG  Gesetz \u00fcber das Apothekenwesen   \nAPR  Annual Product Review  USA  \nAPTT Activated partial thromboplastin time  \nAPV  Arbeitsgemeinschaft f\u00fcr Pharmazeutische \nVerfahrenstechnik   \nAQL  Acceptable Quality Level  Maximum percent defe ctive that \ncan be considered satisfactory \nas a process average \nAQOL  Assessment of Quality of Life   \nAR  Assessment Report   \nAR Adverse Reaction  \nARD  Applicant\u2019s Response Document  \nARIN  American Registry for Internet Numbers   \nARR  absolute risk rate   \nARTG  Australian Register of Therapeutic Goods   \nAs Arsen  \nAS Aminos\u00e4ure  \nASA  American Society of Anaesthesiology   \nASCO  American Society of Clinical Oncology   \nASEAN Association of Southeast Asian Nations  \nASI  Arzneimittelschnellinformation  Ma\u00dfnahme des B fArM bei \nRisikoverdacht eines \nArzneimittels  \nASK-Nummer  Arzneimittelklassifikationsnummer des B fArM   \nASMF  Active Substance Master File   \nASMR  Am\u00e9lioration du Service M\u00e9dical Rendu   \nASR Annual Safety Report  \nAST  Aspartate Transaminase   \nASTM  American Society for Testing and Materials   \nATC  Acute Toxic Class   \nATC/Vet.  Anatomical Therapeutical Chemical \n(Code)/Veterinary   \nATC-Code  Anatomisch Therapeutisch Chemischer Code \nder WHO   \nATMP Advanced Therapy Medicinal Product  5 \n Short Cut Complete Name  Additional Information  \nATP  Adenosine-triphosphat   \nATP Federal Act on Therapeutic Products (Schweiz) \nATS  Application Tracking System   \nAUC  Area Under the Curve  \n  \nAudit Synonym Inspection Systematic and documented \nverification of the implementation of a quality \nmanagement system or elements of such a \nsystem.  External and internal audits.  \nAVP  Arzneiverordnung in der Praxis   \nAVV-R\u00dcB Allgemeine Verwaltungsvorschrift Rahmen-\n\u00dcberwachung  \nAVWG  Arzneimittelversorgungs-\nWirtschaftlichkeitsgesetz   \nAWB  Anwendungsbeobachtungen   \nAWMF  Arbeitsgemeinschaft der wissenschaftlichen \nFachgesellschaften   \nAZT  Azidothymidin (HIV treatment)   \nBA\u00c4K  Bundesausschuss der \u00c4rzte und \nKrankenkassen   \nB\u00c4  Bio\u00e4quivalenz   \nB\u00c4K  Bundes\u00e4rztekammer   \nB\u00c4O  Bundes\u00e4rzteordnung   \nBAG Bundesamt f\u00fcr Gesundheit (Schweiz) \nBAH  Bundesfachverband der Arzneimittelhersteller \ne.V.   \nBAI  Bundesverband der Arzneimittelimporteure   \nBAN  British Approved Names  \nBanz Bundesanzeiger  \nBatch  Quantity of a product originating from one \nmanufacturing run, assumed to be \nhomogenous Synomym: Lot \nBAZ  Bundesanzeiger   \nBB  Bureau of Biologics  jetzt: CBER  \nBBS  Bulletin Board System   \nBCE  beneficial clinical event   \nBCG  Bacille Calmette Gu\u00e9rin   \nBCG  Bio-Coordination Group   \nBCS  Biopharmaceutics Classification System   \nBDFA  Bureau of Food and Drug Analysis Taiwan   \nBE Bioequivalence  \nBEMA  Benchmarking of European Medicines \nAgencies   \nBER Base Excision Repair  \nBEUC  Bureau Europ\u00e9en des Unions de \nConsommateurs  European Consumers\u2019 \nOrganisation \nBfArM  Bundesinstitut f\u00fcr Arzneimittel und \nMedizinprodukte   \nBfT  Bundesverband f\u00fcr Tiergesundheit e.V.   \nBGA  Bundesgesundheitsamt  Exekutive des BMG bis 19 94 \n(Aufl\u00f6sung in Einzelinstitute)  \nBGI  Bundesgesundheitsinstitut  6 \n Short Cut Complete Name  Additional Information  \n \nBgVV  Bundesinstitut f\u00fcr gesundheitlichen \nVerbraucherschutz und Veterin\u00e4rmedizin jetzt: BVL  \nBIO  Biotechnology Industry Association   \nBIRA  fr\u00fcher: The British Institute of Regulatory \nAffairs jetzt: TOPRA  \nBKK-BV  Bundesverband der Betriebskrankenkassen   \nBkostV-MPG  Medizinprodukte-Geb\u00fchrenverordnung   \nBLA  Biologics Licence Application   \nBMA  British Medical Associations   \nBMG  Bundesministerium f\u00fcr Gesundheit   \nBMI  Bundesministerium des Inneren   \nBMJ  British Medical Journal   \nBMP  biological medicinal product   \nBMU  Bundesministerium f\u00fcr Umwelt, Naturschutz \nund Reaktorsicherheit   \nBMWP  Biosimilar Medicinal Products Working Party E xpertenfachgruppe bei der \nEMA  \nBNF  British National Formulary   \nBOB  Bundesoberbeh\u00f6rde   \nBOH  Board of Health   \nBOPST  Bundesopiumstelle  Abt. des BfArM \nBP  B\u00fcndelpackung   \nBP  British Pharmacopeia   \nBPAD  bipolar affective disorder   \nBPC  British Pharmacopoeia Commission   \nBPCA  Best Pharmaceuticals for Children Act  US, pr evisously known as \n\u201cpediatric exclusivity\u201d  \nBPD  diastolic blood pressure   \nBPG Best Practice Guide  \nBPI  Bundesverband der Pharmazeutischen \nIndustrie   \nBPMRG  British Pharmaceutical Market Research \nGroup   \nBPS  systolic blood pressure   \nBPWP  Blood Product Working Party  Expertenfachgrup pe bei der \nEMA  \nBrAAP  British Association of Pharmaceutical \nPhysicians   \nBS Benannte Stelle  \nBSI  Bundesamt f\u00fcr Sicherheit in der \nInformationstechnik  Sitz in Bonn  \nBRAS  Belgian Regulatory Affairs Society   \nBSA  Body Surface Area   \nBSE  Bovine Spongiforme Encephalopathy   \nBSG  Bundessozialgericht   \nBTGC  Bio-Technology General Corporation   \nBtMAHV  Bet\u00e4ubungsmittel-Au\u00dfenhandelsverordnung   \nBtMBinHV  Bet\u00e4ubungsmittel-Binnenhandelsverordnung   \nBtMG  Bet\u00e4ubungsmittelgesetz   \nBtMVV  Bet\u00e4ubungsmittel-Verschreibungsverordnung   \nBverwG  Bundesverwaltungsgericht   7 \n Short Cut Complete Name  Additional Information  \n \nBVL  Bundesamt f\u00fcr Verbraucherschutz und \nLebensmittelsicherheit   \nBWP  Biologics Working Party  Expertenfachgruppe be i der \nEMA  \nC Kohlenstoff  \nCA Conjoint Analysis  \nCA  Competent Authority  (Regulatory body charged w ith \nmonitoring compliance with \nnational, European Member \nState, statutes and regulations)  \nCA  Contract Acceptor   \nCABG  Coronary Artery Bypass Graft Surgery   \nCAD  Coronary Artery Disease   \nCADREAC  The Collaboration Agreement between Drug \nRegulatory Authorities in European Union \nAssociated Countries   \nCADRMP  Canadian Adverse Drug Reaction Monitoring \nProgram   \nCAMA  Computer Assisted Marketing Application US   \nCANDA  Computer Assisted New Drug Application \nElectronic Submission in the US  no longer existing  \nCAP  Community Acquired Pneumonia   \nCAP Centrally authorized product  \nCAPA  corrective and preventive actions   \nCAPLA  Computer-assisted Product License \nApplication (see PLA)   \nCAPLAR  Computer-assisted Product License \nAgreement Review (FDA)   \nCAPRA  Canadian Association of Pharmaceutical \nRegulatory Affairs   \nCARICOM  The Caribbean Community and Common \nMarket  organization of 15 caribbean \nnations and dependencies  \nCAS  Chemical Abstracts Service  (American Chemical  Society)  \nCAST  Cardiac Arrhythmia Suppression Trial  (USA)  \nCAT Committee for Advanced Therapies  \nCAVOD Clinical Added Value of Orphan Drugs Working Party \nCBCTN  Community Based Clinical Trials Network   \nCBE Changes Being Effected  \nCBER  Center for Biologics Evaluation and Research \nCommittee for the evaluation of biologic \nProducts at the FDA  (scientific body)  \nCBF  cerebral blood flow   \nCBI  Confederation of British Industry   \nCC  Change Control   \nCCD  Canadian Drugs Directorate   \nCCDC  Certified Clinical Research Coordinator. See \nalso ACP   \nCCDS  Company Core Data Sheet  \n  \nCCS  Canadian Cardiovascular Society (scoring \nsystem)   8 \n Short Cut Complete Name  Additional Information  \nCCS  container closure system   \nCCSI  Company Core Safety Information   \nCd Cadmium  \nCD  circular dichronism   \nCDA Clinical Document Architecture  \nCDC  Centres for Disease Control (Atlanta, GA)   \nCDE  Center for Drug Evaluation technical \nevaluation  institution for drug registration \nadministration of the Chinese \nSFDA  \nCDER  Center for Drug Evaluation and Research \nCommittee for the evaluation of human drugs \nat the FDA  \n (scientific body) \nCDP  Clinical Data Package   \nCDP  Clinical Development Plan   \nCDRH  Centre for Drug Evaluation and Research \n(FDA)   \nCDS  Core Data Sheet   \nCDSM  Committee on Drug Safety of Medicines  Commit tee of external experts \nempowered by MCA (advisory \nboard)  \nCE  Conformit\u00e9 Europ\u00e9enne   \nCE  capillary electrophoresis   \nCEC  Commission of the European Committee   \nCEEC  Central Eastern European Countries  Geographi cally assigned  \nCEN Comit\u00e9 Europ\u00e9en de Normalisation European Commi ttee for \nStandardization \nCENELEC Europ\u00e4isches Komitee f\u00fcr elektrotechnische \nNormung  \nCEO Chief Executive Officer Gesch\u00e4ftsf\u00fchrer, Vorsta nd \nCEP  Certificate of Suitability to the Monographs o f \nthe European Pharmacopoeia   \nCER Comparative Effectiveness Research  \nCESP Common European Submission Plattform  \nCFC  chlorofluorocarbon   \nCFDA China\u2019s FDA  \nCFR  Code of Federal Regulations Official \nRegulatory Announcements in the US   \nCG  contract giver   \ncGMP  current Good Manufacturing Practices US \nGMP document 21CFR211   \nCHD  Coronary Heart Disease   \nChemG  German Law on Chemicals  Chemikaliengesetz \nCHF  congestive heart failure   \nCHMP  Committee for Medicinal Products for Human \nUse  \nCHO  Chinese Hamster ovary   \nCID  collision-induces dissociation   \nCIOMS  Council for International Organisations of \nMedical Science Postapproval international \nADR reporting UK \nCIOMS  Centerwide Oracle Management Information  9 \n Short Cut Complete Name  Additional Information  \nSystem US (FDA)  \nCIS  Commonwealth of Independent States   \nCl Chlor  \nCLIA  Clinical Laboratory Improvements \nAmendments   \nCLL  chronische lymphatische Leuk\u00e4mie   \nCmax  maximale Plasmakonzentration   \nCMC Chemistry, Manufacturing, Control Term used in the US and \ncorresponds to Modul 3 in the \nEU \nCMDh Coordination group for Mutual recognition and \nDecentralized procedure (human)  (CMD h = human; CMD v = \nveterinary) \nCMDv  group Coordination group for Mutual \nrecognition and Decentralized procedure \n(veterinary)   \nCME continuing medical education  \nCMR  Centre for Medicines Research   \nCMS  Concerned Member State(s) Subsequent member st ates in \nthe MRP  \nCMV  Cytomegalovirus   \nCND Commission on Narcotic Drugs Suchtstoffkommissi on (UN) \nCNS  central nervous system   \nCNSLD  Chronic Non-Specific Lung Disease   \nCO  clinical overview   \nCOA certificate of analysis  \nCOC Cyclic Olefin Copolymer  \nCOFEPRIS  Comisi\u00f3n Federal para la Protecci\u00f3n contr a \nRiesgos Sanitarios  Mexikanische \nGesundheitsbeh\u00f6rde \n(Bundeskommission zum \nSchutz gegen \nGesundheitsrisiken)  \nCOM  Commission (Document)   \nCOMET Single Cell Gel Electrophoresis assay  \nCOMISA  Conf\u00e9d\u00e9ration Mondiale de l\u2019Industrie de la  \nSant\u00e9 Animale   \nCOMP  Committee for Orphan Medicinal Products  Loca ted at the EMA  \nCONEP  National Commission for Ethics in Research  Ethikkommission in \nLateinamerika  \nCOPD  Chronic Obstructive Pulmonary Disease   \nCOS  Certificate of Suitability   \nCOSTART  Coding Symbols for a Thesaurus of Adverse \nReaction Terms   \nCP  Centralised Procedure  One of the procedures fo r \nmarket authorization in the EU \nCP  Concept Paper   \nCPA  Commonwealth of Pharmaceutical \nAssociation   \nCPI  Consumer price index   \nCPM  Centre for Pharmaceutical Medicine   \nCPMP  Committee for Proprietary Medicinal Products  siehe auch: CVMP  \nCPP (CoPP)  Certificate of Pharmaceutical Product  Synonym to FSC (Free Sales \nCertificate)  10 \n Short Cut Complete Name  Additional Information  \nCPR  Cardiopulmonary Resusciation   \nCPSC  Consumer Product Safety Commission  (USA)  \nCPV continuous process verification  \nCQA  clinical quality assurance   \nCQA Critical quality attribute  \nCr Chrom  \nCR  Commission Regulation   \nCR Child resistant siehe auch SF \nCR Clinical Reviewer  \nCRA  Clinical Resarch Assistant/Associate   \nCRADA  Cooperateive Research and Development \nAgreement (with NIH)   \nCRC  Clinical Resarch Coordinator See also CCRC  \nCRD  Common Renewal Date   \nCRF  Case Report Form / Record Form Patient \nforms from clinical studies   \nCRF  Code of Federal Regulations   \nCRIOC  Centre de Recherche et d\u2019Information des \nOrganisations de Consommateurs   \nCRO  Contract Research Organization   \nCSDD  Centre for the Study of Drug Development   \nC-Section Cesarian-Section  \nCSI  core safety information   \nCSM  Committee on Safety of Medicines  Comparable t o A-Kommission of \nBfArM in Germany  \nCSM  Clinical Study Manager   \nCSO  Consumer Safety Officer (FDA)   \ncSPC  core Summaries of Products Characteristics   \nCSS  Company Sponsored Study   \nCSV  Computer Systems Validation   \nCT  clinical trial   \nCT Controlled Terms  \nCTA  Clincal Trial Application/Authorisation   \nCTC  Clinical Trial Certificate Clinical trial lice nce in \nthe UK   \nCTD  Common Technical Document  Single dossier stru cture for the \nEU, USA and Japan  \nCTMP  Clinical Trial on Marketed Product  (UK) \nCTN  Clinical Notification Procedure  Australien \nCTS  Communication Tracking System (of \nMRP)/Central Tracking System   \nCTWP  Cell Therapy Working Party  Expertenfachgrupp e bei der \nEMA  \nCTX  Clinical Trial Exemption  Clinical trial licen ce in the UK \nand Australia \nCu Kupfer  \nCVM  Centre for Veterinary Medicine  (FDA) \nCVMP  Committee for Medicinal Products for \nVeterinary Use  Committee for the evaluation of \nanimal drugs at the EMA \n(scientific body)  \nCYP Cytochrome P450  \nCZ Climatic zone  11 \n Short Cut Complete Name  Additional Information  \nCZE Capillar zone elctrophorese  \nDA  Decision Analysis Modul 12, Unterlagen Herr \nJopp   \nDAB  Deutsches Arzneibuch   \nDAC  Deutscher Arzneimittel Codex   \nDAD Diodenarray-Detector  \nDAHTA  Deutsche Agentur f\u00fcr Health Technology \nAssessment   \nDALY  Disability-Adjusted Life Years oder Disease-\nAdjusted Life Years   \nDAMOS  Drug Application Methodology on Optical \nStorage  Co-operative approach on \nelectronic submission between \nBfArM and industry  \nDARE  Datebase of Abstracts of Reviews of Effects   \nDAV  Deutscher Apothekerverein   \nDAWN  Drug Application Methodology with Optical \nStorage   \nDAZ  Deutsche Apotheker Zeitung   \nDCC  deleted in colorectal cancer   \nDCP  Decentralised Procedure  Dezentrales Verfahren   \nDDD  defined daily dose   \nDDM  Drug Dossier Manager   \nDDPS  Detailed Description of the \nPharmacovigilance System   \nDDR  Drug Registratioh Department of SFDA   \nDDX  Doctor\u00b4s and Dentist\u00b4s Exemption   \nDEA  Drug Enforcement Agency (US)   \nDEEC  Drug Evaluation Experts Committee (China)  Co nstituted of specialists to \nprovice evaluation advice to the \nChinese  \nDEL Defect evaluation lists  \nDEN  Drug Experience Network   \nDeNIC  Deutsches Network Information Center   \nDER Drug-Extract-Ratio  \nDEREK  Deductive Estimation of Risk from Existing \nKnowledge   \nDES  Data Exchange Standard Specification   \nDES  Diethylstilbestrol  \n synthet. \u00d6strogen  \nDESI  Drug Efficacy Study Implementation Notice  (F DA, to evaluate drugs in use \nprior to 1962) \nDFG  Deutsche Forschungsgemeinschaft   \nDG  Directorate Generale Directorate General of \nthe Commission in Brussels  (e.g. DG III for Pharmaceuticals)  \nDG ENTR  DG Enterprise and Industry  \n  \nDG SANCO  DG Health and Consumer Protection   \nDG III  Directorate Generale III   \nDGD  Now OGD  formerly CBER`s Division of \nGeneric Drugs  \nDGPT  Deutsche Gesellschaft f\u00fcr experimentelle und \nklinische Pharmakologie und Toxikologie   12 \n Short Cut Complete Name  Additional Information  \nDG XIII  European Commission Directorate-General \nXIII  Telecommunications, \ninformation market, and \nexploitation of research  \nDGPharMed  Deutsche Gesellschaft f\u00fcr Pharmazeutisch e \nMedizin  ehemals F\u00c4PI  \nDHEW  Department of Health, Education and Welfare  now split into Department of \nHealth & Human-Services and \nDepartment of Education \nDHPC  Direct Healthcare Professional \nCommunication   \nDHSS  Department of Health and Social Services   UK  \nDHT Dihydrotestosteron  \nDIA  Drug Information Association   \nDi\u00e4tV Di\u00e4tverordnung  \nDIMDI  Deutsches Institut f\u00fcr Medizinische \nDokumentation und Information   \nDIMDIV  DIMDI-Verordnung   \nDIR  Directive   \nDITR  Deutsches Informationszentrum f\u00fcr \ntechnische Regeln   \nDKFZ  Deutsches Krebsforschungszentrum   \nDKG  Deutsche Krankenhausgesellschaft   \nDLP  Data Lock Point  (s. PSU)  \nDMC  Date monitoring committee   \nDMF  jetzt: ASMF   \nDMP  Disease Management Program   \nDMS  Document Management System   \nDOD  Department of Defense   \nDoH  Department of Health  (UK and South Africa) \nDP Drug Product  \nDPC-PTR Act.  Drug Price Competition and Patent Ter m \nRestoration ACT  1984 (also known as Waxman-\nHatobill)  \nDPhG  Deutsche Pharmazeutische Gesellschaft   \nDPI  Dry Powder Inhaler   \nDQ  Design Qualification Subset of Validation   \nDR Discipline Review Letter  \nDRA  Drug Regulatory Affairs   \nDRAM  Drug Regulatory Affairs Manager   \nDRG  Diagnosis Related Groups   \nDRG  Division of Research Grants  (NIH) \nDS  Drug Safety   \nDSC Drug Safety Communication  \nDSC  Differential Scanning Calorimetry   \nDSEB  Drug Safety and Evaluation Branch  Australien  \nDSI  Division of Scientific Investigations (FDA)   \nDSM  Diagnostic and Statistical Manual  (of the Ame rican Psychiatry \n(Association)  \nDSMB  Data and Safety Monitoring Board   \nDSMC  Data and Safety Monitoring Committee   \nDSNP  Development of Standardized Nomenclature \nProject FDA \nDTA Differenz(ial)-thermische Analyse  13 \n Short Cut Complete Name  Additional Information  \nDTD  Document Type Definition   \nDTI  Department of Trade and Industry (UK)   \nDTP  Diphtherie-Tetanus-Pertussis-Impfung   \nDUNS-Nr Data Universal Numbering System-Number  \nDCVR  Developing Countries\u00b4 Vaccine Regulators\u00b4 \nNetwork  E2B ICH guideline re. Electronic \nformat for exchange of drug \nsafety information  \nE2B Standard f\u00fcr elektronische \nNebenwirkungsmeldungen an die Beh\u00f6rde  \nE2E  ICH guideline reg. pharmacovigilance \nplanning   \nEAASM European Alliance for Access to Safe \nMedicines  \nEAB  Ethical Advisory Board  term used in some nati ons for \ngroups similar to IRBs and IECs \nEAD  early after depolarization   \neAF electronic application form  \nEAMIV Elektronische Arzneimittelinformations-\nVerordnung  \nEAMS Earlier Access to Medicines  \nEA-Report  environment assessment report   \nEATG European AIDS Treatment Group  \nEbD Erg\u00e4nzende bilanzierte Di\u00e4ten  \nEBHC evidence-based health care  \nEBM  evidence-based medicine  evidenzbasierte Mediz in \nEBU  European Blind Union   \nEC  European Commission  in documents older than th e mid \n1980s  \nEC  Ethics Committee   \nEC  European Community   \nECARS  European Computer Assisted Regulatory \nSubmission   \nECG  Electrocardiogram   \nECJ  European Court of Justice   \nECM Enterprise Content Management System  \nECMA  European Carton Makers Association   \nECOSOC  Economic and Social Council  UNO \nECPHIN  European Community Pharmaceutical \nProducts Information Network   \nECRI  Emergency Care Research Institute   \neCTD  electronic Common Technical Document   \nECU  European Currency Unit   \nEDIFACT  Electronic Data Interchange for \nAdministration, Commerce, and \nTransportation   \nEDI  Electronic Data interchange   \nEDMF  European Drug Master File   \nEDMS  Electronic Document Management System   \nEDS  Electronic Data Submission   \nEDQM  European Directorate for the Quality of \nMedicines and HealthCare  Gremium des Europarates mit \nSitz in Stra\u00dfburg  \nEEA  European Economic Area   14 \n Short Cut Complete Name  Additional Information  \nEEC  European Economic Community,  now EU; some reg ulatory \ndocuments still have EEC \ndocument numbers  \nEEG  electroencephalogram   \nEFGCP  European Forum on Good Clinical Practice  Ev ere, Belgium \nEFPIA  European Federation of Pharmaceutical \nIndustries\u2019 Associations   \nEFQM  European Foundation for Quality \nManagement   \nEFSA European Food Safety Authority Europ\u00e4ische Beh \u00f6rde f\u00fcr \nLebensmittelsicherheit \nEFTA  European Free Trade Association  Western Euro pe countries which \nare not members of the EC  \nEG  Europ\u00e4ische Gemeinschaft   \nEGA  European Generic Medicines Association   \neGK  elektronische Gesundheitskarte   \nEGRL  EG-Richtlinie   \nEGV Vertrag zur Gr\u00fcndung der Europ\u00e4ischen \nGemeinschaft  \nEINECS  European register of old chemicals \nEurop\u00e4isches Altstoffverzeichnis   \nEIR  Establishment Inspection Report  FDA \nEK  Ethikkommission   \nELA  Establishment License Application  FDA \nELINCS  European list of registered chemicals   \nELISA  Enzym-Linked Immunosorbent Assay  Bindungsas say \nEMA  European Medicines Agency  vor 11/2009: EMEA \nEMCDDA  European Monitoring Centre for Drug and \nDrug Addiction  WHO  \nEmLib Essential Medicines Library  \nEMP  siehe EuroPharm   \nEMS  Electronic Mail Service   \nENR  Einreichungsnummer   \nEOI  Expression of Interest  WHO  \nEP  European Parliament   \nEPAR  European Public Assessment Report   \nEPHMRA  European Pharmaceutical Marketing \nResearch Association   \nEPI  European Product Index   \nEPI  Expanded Programme on Immunization  WHO  \nEPITT  European Pharmacovigilance Issues Tracking \nTool   \nEPO  European Patent Office   \nEPO  erythropoietin   \nEPRG  European Pharmacovigilance Research \nGroup   \nEPS  Entwicklungs-Projekte-Steuerungskonferenz   \nERA Environmental Risk Assessment  \nERG  Electroretonogram   \nESCOP  European Scientific Cooperative for \nPhytotherapy   \nESG Electronic Submission Gateway  15 \n Short Cut Complete Name  Additional Information  \nESI  Electrospray Ionization   \nESOP  European Society for Pharmacovigilance   \nESR  Erythrocyte Sedimentation Rate   \nESRA  European Society of Regulatory Affairs   \nESTRI  Electronic Standards for the Transmission of  \nRegulatory Information   \nETF  EMA Task Force   \nETOMEP  European Technical Office for Medicinal \nProducts  EMA \nEU  European Union  Cooperation of 26 European \nCountries  \nEUDRACT  European Clinical Trials Database   \nEUDRANET  European Union Drug Regulatory Authoritie s \nNetwork  (EMA)  \nEUFEPS  European Federation of Pharmaceutical \nSciences   \nEuG  Europ\u00e4isches Gericht,  erste Instanz  \nEuGH  Europ\u00e4ischer Gerichtshof   \nEU-KOM Europ\u00e4ische Kommission  \nEURD European Union Reference Date \nand frequency of submission of periodic \nsafety update reports (PSURs)  \nEuroPharm  European Pharmacopoeia   \nEURS  European Review System  Reviewsystem, das die  \nBeh\u00f6rden bei der Pr\u00fcfung von \ne-CTDbasierten \nZulassungsdossiers unterst\u00fctzt  \nEUSES  European Union System for the Evaluation of \nSubstances   \nEVCTM  EudraVigilance Clinical Trial Module   \nEVMPD  EudraVigilance Medicinal Products Directory   \nEVPM  Earned Value Project Management   \nEVPRM Eudra Vigilance Medicinal Product Report \nMessage  \nEVV Eudra Vigilance Veterinary Module  \nEW  Entwicklung   \nEWP  Efficacy Working Party  Mittlerweile aufgel\u00f6st  \nEWR  Europ\u00e4ischer Wirtschaftsraum   \nF Fl\u00e4che  \nF\u00c4PI  Fachgesellschaft der \u00c4rzte in der \nPharmazeutischen Industrie e.V.  German Association of \nPhysicians in the \nPharmaceutical Industry \nFAH  Forschungsvereinigung der \nArzneimittelhersteller   \nFAO  Food and Agriculture Organisation of the \nUnited Nations Farmindustria  The Association of the Italian \nPharmaceutical Manufacturers \nFCC Food Chemical Codex \n(US)  \nFD  Floppy disk   \nFDA  Food and Drug Administration  USA \nFDAAA Food and Drug Administration Amendment \nAct  16 \n Short Cut Complete Name  Additional Information  \nFDASIA FDA Safety andn Innovation Act  \nFD&C  Food, Drugs and Cosmetics Act (US)   \nFDC  Fixed-dose Combination   \nFDLI  The Food and Drug Law Institute   \nFe Eisen  \nF&E  Forschung und Entwicklung   \nFEDESA  F\u00e9d\u00e9ration Europ\u00e9enne de la Sant\u00e9 Animale   \nFEIBA  Factor Eight Inhibitor Bypassing Activity   \nFHD  First Human Dose   \nFI Fachinformation  \nFICI  Federation of Irish Chemical Industries   \nFID  Flammenionisationsdetektor   \nFIFARMA  Federaci\u00f3n Latinoamericana de La Industria  \nFarmac\u00e9utica  Latin American Federation of the \nPharmaceutical Industry  \nFIM  first-in-man   \nFIP  F\u00e9deration Internationale Pharmaceutique   \nFIZ Technik  Fachinformation Technik   \nFMEA  Failure Mode Effect Analysis   \nFMECA  Failure Mode, Effects and Criticality Analys is   \nFO  Forschung   \nFOI  Freedom of Information   \nFOIA  Freedom of Information Act (USA)  FDA self-ob ligation to publish \ninformation  \nFPA  Family Planning Association   \nFPC  Family Practitioner Committees   \nFPC Federal Partners Collaboration  \nFPIF  The Finnish Pharmaceutical Industry \nAssociation   \nFR Federal Register  \nFRCP  Fellow of the Royal College of Physicians,  s ometimes followed by a place \nname \u2013 for example, FRCP \n(Edin.) \u2013 that indicates a \nuniversity medical school  \nFSC  Free Sales Certificate  information on product  and \nmanufacturer from the country of \norigin siehe auch CPP  \nFSCA  Field Safety Corrective Action  Sicherheitsre levante korrektive \nMa\u00dfnahme im Feld  \nFSH  Follikel-stimulierendes Hormon   \nFT  Freitext   \nFTA  fault tree analysis   \nFTC  Federal Trade Commission  USA \nFTP  File Transfer Protocol   \nFVAR  Final Variation Assessment Report   \ng  Gramm   \nG  Guideline   \nGA Gegenanzeigen  \nGABA Gamma-aminobutyric acid  \nGACP Good Agricultural and Collection Practice  \nGALP  Good Automated Laboratory Practice   \nGAMP  Good Automated Manufacturing Practice   17 \n Short Cut Complete Name  Additional Information  \nGAO  General Accounting Office  U.S. government  \nGAP  Good Analytical Practices   \nGATB  Global Alliance for Tuberculosis   \nGATT  General Agreement of Tariffs and Trade   \nG-BA/GBA  Gemeinsamer Bundesausschuss   \nGC  gas chromatography   \nGCC  Gulf Cooperation Council  Kooperationsrat der arabischen \nGolfstaaten  \nGCC-DR  Gulf Central Committee for Drug Registratio n  Beh\u00f6rde zur F\u00f6rderung der \nZusammenarbeit der GCC-\nMitglieder im Bereich der AM-\nZulassung  \nGCP  Good Clinical Practice   \nGCRP  Good Clinical Research Practice   \nG-CSF  granulocyte colony stimulating factor   \nGDP  good distribution practice   \nGDUFA Generic Drug User Fee Amendment  \nGenTG  Gentechnikgesetz Gesetz zur Regelung von \nFragen der Gentechnik \nGEROLIT  Gerontologische Literaturdatenbank des \ndeutschen Zentrums f\u00fcr Altersfragen (DZA)   \nGew.O.  Gewerbeordnung   \nGFAP Glial Fibrillary Acidic Protein  \nGfI  Guidance for Industry   \nGFP  Gute fachliche Praxis   \nGGIMP  Ger\u00eancia de Inspe\u00e7\u00e3o e Control de \nMedicamentos e Productos  Brasilianische \n\u00dcberwachungsbeh\u00f6rde (General \nOffice of Inspection and Control \nof Inputs, Drugs, and Products \nGGMED  Ger\u00eancia de Medicamentos  Brasilianische \nZulassungsbeh\u00f6rde (General \nOffice of Drug)  \nGHTF  Global Harmonization Task Force   \nGI Gebrauchsinformation  \nGI  Gastrointestinal   \nGK Globale Konzeption  \nGKV  Gesetzliche Krankenversicherung   \nGKV-SpiV  Spitzenverband der Gesetzlichen \nKrankenversicherungen   \nGKV-WSG  GKV-Wettbewerbsst\u00e4rkungsgesetz   \nGL Guideline  \nGLP  Good Laboratory Practice   \nGMA Global Marketing Authorisation  \nGMC  General Medical Council   \nGM-CSF Granulocyte Macrophage Colony Stimulating \nFactor   \nGMDN Global Medical Device Nomenclature  \nGMDS Deutsche Gesellschaft f\u00fcr Medizinische \nInformatik, Biometrie und Epidemiologie e.V  \nGMG  GKV-Modernisierungsgesetz   \nGMO  Genetically Modified Organism   \nGMP  Good Manufacturing Practice   18 \n Short Cut Complete Name  Additional Information  \nGMSC  General Medical Services Committee   \nGNP  Gross National Product   \nG\u00d6 Gesundheits\u00f6konomie  \nGOS  Glasgow Outcome Score   \nGP  General Practitioner   \nGPIA  Generic Pharmaceutical Industry Association   \nGPSP Good Practice Systems and Programs  \nGPUE  Groupement de Pharmaciens Europ\u00e9ens   \nGRP  Good Regulatory Practice   \nGSAV Gesetz f\u00fcr mehr Sicherheit in der \nArzneimittelversorgung  \nGSG  Gesundheitsstrukturgesetz   \nGSL  General Sales List (U.K.)   \nGST  Glutathion-S-Transferase   \nGTWP  Gene Therapy Working Party  Expertenfachgrupp e bei der \nEMA \nGUI  Graphical User Interface   \nG\u00dcG  Grundstoff-\u00dcberwachungsgesetz   \nGUSTO  Global Utilisation of Streptokinase and TPA in \nthe Occlusion of Coronary Arteries   \nGVD  gemeinsames Verl\u00e4ngerungsdatum   \nGVO  Genetisch ver\u00e4nderter Organismus  (s. GMOS)  \nGVP Good Pharmacovigilance Practice  \nGWG  Geldw\u00e4schegesetz   \nHAB  Hom\u00f6opathisches Arzneibuch   \nHACCP  Hazard Analysis of Critical Control Point   \nHAI Health Action International   \nHAS  Haute Authorit\u00e9 de Sant\u00e9 French National \nAuthority for Health   \nHAZOP  Hazard Operability Analysis   \nHBV  Hepatitis B virus   \nHC HCQC  Proton-carbon Heteronuclear single Quantum  \nCorrelation   \nHC HMBC  Proton-carbon Heteronuclear Multiple-bond \nCorrelation   \nHC COSY  Proton-carbon Correlated Spectroscopy   \nHCV  Hepatitis C Virus  \nHCFA  Health Care Financing Administration  (of the  HHS)  \nHDPE  High density polyethylene   \nHDL  high-density lipoprotein   \nHED  human equivalent dose   \nHepB  Hepatitis B   \nHEVRA  Heads of European Veterinary Regulatory \nAuthorities for Medicinal Products   \nHg Quecksilber  \nHGB  Handelsgesetzbuch   \nHgb  Hemoglobin   \nHH ROESY  Proton-carbon rotating frame Overhauser \neffect spectroscopy   \nHHS  Health and Human Services   \nHib  haemophilus influenza Typ b   19 \n Short Cut Complete Name  Additional Information  \nHIMA  Health Industry Manufacturers Association   \nHISPP  Healthcare Informatics Standards Planning \nPanel   \nHIV  Human Immunodeficiency Virus   \nHL7  Healthcare Linkage version 7   \nHMA  Heads of Medicines Agencies   \nHMEC Human Medicines Expert Committee (Schweiz) \nHMG-CoA reductase  3-Hydroxy-3-methylglutaryl-Coenzym-A-\nReduktase oder \u00df-Hydroxy-\u00df-methylglutaryl-\nCoenzym-A-Reduktase   \nHMO  Health Maintenance Organisation  (US)  \nHMP  Herbal Medicinal Product   \nHMPC  Committee on Herbal Medicinal Products   \nHMPWP  Herbal Medicinal Products Working Party   \nHNSTD Highest Non-Severly Toxic Dose  \nHOA  Heads of Agencies   \nHP  Healthcare Professional   \nHPFB  Health Products and Food Branch  kanadische \n\u00dcberwachungsbeh\u00f6rde; s. auch \nTPD \nHPLC  high performance liquid chromatography   \nHPV human papillomavirus  \nHR  heart rate   \nHRI  Host related impurities   \nHRT  Hormone Replacement Therapy   \nHS-GC  Headspace-Gas Chromatography   \nHSR  Health Services Research   \nHTA  Health Technology Assessment   \nHTML  Hypertext Mark-up Language   \nHTTPS  Hypertext Transfer Protocol Secure   \nHVAC  Heating, Ventilation and Air conditioning  Sa mmelbegriff f\u00fcr \nL\u00fcftungssysteme  \nHVD  half value duration  Halbwertzeit \nHWG  Heilmittelwerbegesetz   \nHWI  Harnwegsinfektion   \nIANA  Internet Assigned Numbers Authority   \nIARC  International Agency for Research on Cancer, \nLyon   \nIAS  International Accounting Standards   \nIB  Investigator\u2019s Brochure   \nIBD  International Birth Date   \nIBS International biometric society Internationale biometrische \nGesellschaft \nIBS-DR Deutsche Region der Internationalen \nBiometrischen Gesellschaft   \nIC  Informed Consent   \nIC  Ion Chromatography   \nICD  International Classification of Diseases   \nICD-O  International Classification of Diseases for  \nOncology   \nICDRA  International Conference of Drug Regulatory \nAuthorities   20 \n Short Cut Complete Name  Additional Information  \nICER  Incremental cost-effectiveness ratio   \nICF  Internationale Klassifikation der \nFunktionsf\u00e4higkeit, Behinderung und \nGesundheit   \nICH  International Conference on the \nHarmonisation (of Technical Requirements for \nRegistration of Pharmaceuticals for Human \nUse)  \nICP-AES Inductively coupled plasma \u2013 atomic emissio n \nspectroscopy  \nICP-MS Inductively coupled plasma \u2013 mass \nspectroscopy  \nICP-OES  Inductive Coupled Plasma Optical Emission \nSpectroscopy   \nICPM  International Clinical Project Manager   \nICSR  Individual Case Safety Report   \nICTH  International Committee on Thrombosis and \nHaemostases   \nIDE  Investigational Device Exemption  FDA \nIDL Import Drug License  \nIDMA  Indian Drug Manufacturers\u2019 Association   \nIDMC  Independent Data Monitoring Committee   \nIDMP Identification of Medicinal Product  \nIDP  Import Drug Permission   \nIDR  Idiosyncratic drug reaction   \nIEC  Independent ethics committee  See also EAB, IR B, NRB \nIEF Isoelectric focusing  \nIFA  Informationsstelle f\u00fcr Arzneimittel GmbH   \nIFAH  International Federation of Animal Health  Si tz in Br\u00fcssel \nIFAPP International Federation of Association of \nPharmaceutical Physicians   \nIFG  Informationsfreiheitsgesetz   \nIFPMA  International Federation of Pharmaceutical \nManufacturers Association   \nIfSG  Infektionsschutzgesetz   \nIG  The Office of the Inspector General HHS \nIGPA  International Generic Pharmaceutical Alliance    \nIHE  Swedish Institute for Health Economics   \nIHTA  International Health Technology Assessment   \nIIT  investigator initiated study   \nIKS  Interkantonale Kontrollstelle f\u00fcr Heilmittel  Schweiz (jetzt: Swissmedic) \nILSI  International Life Science Institute  Sitz in  Washington D.C. \nIMAP  International Medical Advisory Panel   \nIMCT International Multicenter Clinical Trial  \nIMMED  International Marketed Medicines Database   \nIMP  investigational medicinal product   \nIMPACT  International Medicinal Products Anti-\nCounterfeiting Task Force  Netzwerkaus zahlreichen \nInteressenverb\u00e4nden, \nOrganisationen und staatlichen \nbzw. internationalen Beh\u00f6rden  \nIMPD  Investigational Medicinal Product Dossier   \nINAHTA  International Health Technology Assessment  21 \n Short Cut Complete Name  Additional Information  \nDatabase  \nINCB  International Narcotics Control Board  (UNO) (Internationaler \nSuchtstoffkontrollrat \nIND  Investigational New Drug Application  \nINN  International Non-proprietary Name   \nINTDIS  WHO database of side-effects   \nINTERNIC  The Internet\u00b4s Network Information Centre    \nIPA  International Pharmaceutical Abstracts   \nIPC  In-Process-Control   \nIPK  Inprozesskontrolle   \nIPM  International Project Manager   \nIPPF  International Planned Parenthood Federation   \nIPRO  Independent Pharmaceutical Research \nOrganization.  See also CRO.  \nIPS  Industrial Pharmacists Section   \nIPV  Inactivated Poliomyelitis Vaccination/Virus   \nIPTS  Institute for Prospective Technological \nStudies   \nIQ  Installation Qualification   \nIQWiG  Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit  im \nGesundheitswesen   \nIr Iridium  \nIR Infrarotspektroskopie  \nIR Information Request Letter USA \nIRB  Institutional Review Board   \nIRD  International Registration Document   \nIRDAC  Industrial Research and Development \nAdvisory Committee   \nIRF  International Reviewer Forum   \nISE  Integrated Summary on Efficacy  Part of the ND A for FDA \n(Efficacy)  \nISO  International Standards Organization   \nISOC  Internet Society   \nISS  Integrated Summary on Safety  Part of the NDA for FDA \n(Safety) \nIT  Information Technology   \nIT Index Terms  \nITCVDR  International Technical Consultation on \nVeterinary Drug Registration   \nITT Intention to treat Analyse-Technik, bei der die \nPatienten nach ihrer urspr\u00fcnglichen \nGruppenzuteilung analysiert \nwerden, unabh\u00e4ngig davon, ob sie \ndie zugeordnete (intendierte) \nTherapieform vollst\u00e4ndig, partiell \noder gar nicht erhalten haben \nIUB  International Union of Biochemistry Enzyme \nNomenclature   \nIUD  intrauterine device   \nIUPAC  International Union of Pure and Aplied \nChemistry a In Vitro Diagnostics   \nIVD In-vitro-Diagnostikum  22 \n Short Cut Complete Name  Additional Information  \nIVDMDD  In Vitro Diagnostics Medical Devices Direct ive   \nIVF  In Vitro Fertilization   \nIVF/ET  In Vitro Fertilization/Embryo Transfer   \nIVR  Interactive Voice Responding   \nJAMA  Journal of the American Medical Association   \nJAN Japanese approved names  \nJAPIC  Japan Pharmaceutical Information Center   \nJCAH  Joint Commission for the Accreditation of \nHospitals   \nJCAHO  Joint Commission of Accreditation of Health \nCare Organizations   \nJCPAC  Japanese Central Pharmaceutical Affairs \nCouncil  \n  \nJCPT  Journal of Clinical Pharmacology and \nTherapeutics   \nJCRDD  Journal of Clinical Research and Drug \nDevelopment   \nJCRP  Journal of Clinical Research and \nPharmacoepidemiology   \nJDI Joint Declaration of Intent  \nJEFA  Joint FAO/WHO Expert Committee on Food \nAdditives   \nJGMP  Japanese GMP   \nJP  Japanese Phamacopeia   \nJPMA  Japan Pharmaceutical Manufacturers \nAssociation   \nJRC  European Commission Joint Research Centre   \nKALP  Kalenderpackung   \nKBE  keimbildende Einheiten   \nKBV  Kassen\u00e4rztliche Bundesvereinigung   \nKK  Krankenkasse   \nKFDA  Korea Food and Drug Administration   \nKFEB  Committee for Clinical Pharmacology and \nEthics   \nKM Knowledge Management  \nKMU Kleine und mittlere Unternehmen  \nKPT  Kern Projekt Team   \nKS  Kaposi\u2019s sarcoma   \nKV  Kassen\u00e4rztliche Vereinigung   \nkwV  keine weitere Verl\u00e4ngerung   \nKZBV  Kassenzahn\u00e4rztliche Bundesvereinigung   \nLACNIC  Latin American and Carribean Internet \nAdresses Registry   \nLAG  L\u00e4nderausschuss  Gentechnik \nLAL-Test  Limulus Amoebocyte Lysate Test Pyrogenic \nendotoxins in injectable preparations   \nLAS  Labor-Automationssystem   \nLAS  Lymphadenopathy Syndrome  (= AIDS) \nLAT  Light Authorig Tool   \nLB deutsche Landesbeh\u00f6rde  \nLBBB  Left Bundle Branch Block   23 \n Short Cut Complete Name  Additional Information  \nLC Liquid chromatography  \nLCM  Life-cycle-management   \nLDH  Laktatdehydronegase   \nLDL  low-density lipoprotein   \nLEEM  Les Entreprises du M\u00e9dicament  Franz\u00f6sischer Verband der \nMedikamentenhersteller  \nLFGB  Lebensmittel-und Futtermittelgesetzbuch   \nLH  Luteinisierendes Hormon   \nLIGA  life gained table   \nLIMS  Laboratory Information Management System   \nLM  L\u00f6semittel   \nLMBG  Lebensmittel-und Bedarfsgegenst\u00e4ndegesetz   \nLMR Lebensmittelrecht  \nLMKV Lebensmittel-Kennzeichnungsverordnung  \nLOC  Locally Operating Company   \nLOD  Limit of Detection  Nachweisgrenze \nLOCF  Last Observation Carried Forward   \nLOEL  Lowest Observed Effect Level   \nLOINC Logical Observation Identifier Names and \nCodes   \nLoOI  List of Outstanding issues  Day 180 (CP) \nLoQ  limit of quantification   \nLoQ List of Questions Day 120 (CP) \nLot  franz; Synonym: Batch   \nLPLV  Last Patient Last Visit   \nLSL  Lower Specification Limit   \nLVZ  Lager-und Versandzentren   \nMA Marketing Authorisation   \nMAA Marketing Authorisation Application   \nMAB  monoclonal antibody   \nMABEL  minimally anticipated biological effect leve l   \nMAH Marketing Authorisation Holder   \nMAIL Medicines Act Information Letter  (U.K.)  \nMAL  Medicines Act Leaflet  (U.K.)  \nMALDI Matrix assisted laser desorption/ionization  \nMANSEV  Marketing Authorisation by Network \nSubmission and Evaluation   \nMAO  Monoamine Oxidase   \nMAPP  Manual of Policies and Procedures  Regulatory  procedures manual \nissued by the FDA  \nMCA  fr\u00fcher: Medicines Control Agency (UK);  jetzt:  MHRA \nMCASE  Multiple Computer Automated Structure \nEvaluation   \nMCC  Medicines Control Council  S\u00fcdafrikan. Zulassu ngsbeh\u00f6rde  \nMCH Mean Corpuscular Hemoglobin  \nMCHC Mean Corpuscular Hemoglobin Concentration  \nMCM multi-component mixture  \nMCRC  Medical and Clinical Research Consultants  (U K)  \nMCV Mean Corpuscular Volume  \nMD  Multiple dose   \nMDA  Medical Devices Agency (UK)   24 \n Short Cut Complete Name  Additional Information  \nMDCG Medical Device Coordination Group  \nMDD  Medical Device Directives (EU)   \nMDI  Metered Dose Inhaler; Manic Depressive \nIllness   \nMDK  Medizinischer Dienst der Krankenkassen   \nMDN  Message Disposition Notification   \nMDS  Medizinischer Dienst der Spitzenverb\u00e4nde   \nMDS  Master Data Sheet   \nMDV  Medical Device Vigilance   \nMEB  Medicines Evaluation Board  (Netherlands)  \nMECU  Million ECU   \nMEDDEV  MEDical DEVices   \nMedDRA  Medical Dictionary for Drug Regulatory \nActivities  Result of ICH M1  \nMEDLARS  Medical Literature Analysis and Retrieval \nSystem   \nMedsafe  Neuseel\u00e4ndische Zulassungsbeh\u00f6rde   \nMEFA  The Association of the Danish Pharmaceutical \nIndustry   \nMEGRA  Mitteleurop\u00e4ische Gesellschaft f\u00fcr \nRegulatorische Angelegenheiten e.V.   \nMEMO  Medicines Evaluation and Monitoring \nOrganisation   \nMENA Middle East & North Africa (Nahost und Nordafr ika) \nMEP  Member of the European Parliament   \nMERCOSUR  Mercado Com\u00fan del Sur  Gemeinsamer Markt \nS\u00fcdamerikas  \nMERS  Multiagency Electronic Regulatory \nSubmission   \nMeSH  Medical Subject Headings   \nMg Milligram  \nMGMT Methylguaninemethyltransferase  \nMGV  maximale prozentuale Gesamtverunreinigung   \nMHRA  Medicines and Healthcare products \nRegulatory Agency  (UK)  \nMHLW  Ministry of Health, Labour and Welfare  (Japa n)  \nMIC  Minimum Inhibitory Concentration   \nMIHWAF  Ministry of Healthcare, Welfare and Family  Korea  \nMIMS Monthly Index of Medical Specialities  \nMIST Mexico, Indonesia, South Korea and Turkey  \nml  milliliter   \nmm  millimeter   \nMMR  Maser-Mumps-R\u00f6teln-Schutzimpfung   \nMMV  Medicines for Malaria Venture   \nMn Mangan  \nMNA  \u00b5-Agonist + NA-Reuptake-Inhibitor: \nAnalgetika mit doppeltem Wirkprinzip   \nMo Molybd\u00e4n  \nMOH  Ministry of Health China   \nMOU  Memorandum of Understanding  between FDA and a  regulatory \nagency in another country that \nallows mutual recognition of 25 \n Short Cut Complete Name  Additional Information  \ninspections  \nMP  medicinal product  Deutsch: Arzneimittel (nicht  \nMedizinprodukt !!)  \nMPA  Medical Products Agency  Schwedische \nZulassungsbeh\u00f6rde \nMPAV Verordnung zur Regelung der Abgabe von \nMedizinprodukten  \nMPBetreibV  Medizinprodukte-Betreiberverordnung   \nMPG  Medizinproduktegesetz   \nMPGVwV Allgemeine Verwaltungsvorschrift zur \nDurchf\u00fchrung des MPG  \nMPS  Medizinisch-pharmazeutische \nStudiengesellschaft   \nMPSV  Medizinprodukte-Sicherheitsplanverordnung   \nMPV  Medizinprodukteverordnung   \nMPVerschrV  Verordnung \u00fcber die Verschreibungspflic ht \nvon Medizinprodukten   \nMPVertrV  Verordnung \u00fcber Vertriebswege f\u00fcr \nMedizinprodukte   \nMr Relative molecular mass  \nMR  Mutual Recognition   \nMRA  Mutual Recognition Agreement   \nMRA  Medical Research Associate   \nMRC  Medical Research Council (U.K.)   \nMRFG  Mutual Recognition Facilitation Group   \nMRI  Magnetic Resonance Imaging   \nMRL  maximum residue limit   \nMRP  Mutual Recognition Procedure  One of the proce dures for \nmarketing authorization in the \nEU \nMRSD  maximum recommended starting dose   \nMRT  Magnet-Resonanz-Tomographie   \nMRT Mean residence time Mittlere Verweilzeit \nMS  Member State(s)  Countries organized in the EU  \nMS  mass spectrometry   \nMTC mixed treatment comparison  \nMTD  maximum tolerated dose   \nMTPT  Methylphenyltetrahydropyridine   \nMUMS  Minor Use and Minor Species   \nMVI  Malaria Vaccine Initiative   \nN Stickstoff  \nn.d.  not detected   \nNA  Norepinephrine   \nNA New Approach/Neuer Ansatz  \nNADA  New Animal Drug Application   \nNAF  Notice of Adverse Findings (FDA post-audit let ter)  \nNAFTA North American Free Trade Agreement   \nNAI  no action indicated  (most favourable FDA post -\ninspection classification)  \nNAP nationally authorised product MRP/DCP \nNAS  New Active Substance   \nNAS-NRC  National Academy of Sciences \u2013 National  26 \n Short Cut Complete Name  Additional Information  \nResearch Council  \nNAT National  \nNATRIK  National Reporting and Investigation Centre    UK \nNBE  new biological entity   \nNB-MED  Empfehlungspapiere, welche vom \nEurop\u00e4ischen Erfahrungsaustausch der \nBenannten Stellen im Bereich \nMedizinprodukte (NB-MED), an dem auch \nVertreter der Herstellerverb\u00e4nde und EG-\nKommission teilnehmen, verabschiedet \nwurden   \nNCA  National Competent Authority   \nNCE  New Chemical Entity   \nNCHS  National Centre for Health Statistics (in CDC )   \nNCHSR  National Center for Health Services Research  \n(and Health Care Technology Assessment)  (USA)  \nNCI  National Cancer Institute (NIH)   \nNCO  Non-clinical Overview   \nNCPIE  National Council on Patient Information and \nEducation  (Washington, DC)  \nNCR  no carbon required   \nNCRP Northwest Clinical Research Professionals Port land, OR \nNCVIA  National Childhood Vaccine Injury Act (1986)    \nNDA  New Drug Approval/Application   \nNDAB  National Drug Advisory Board   \nNDS  New Drug Submission  (Kanada)  \nNDS  new drug study  (Canada\u2019s new drug application )  \nNECSI  New England Complex Systems Institute   \nNEDO  National Economic Development Office   \nNEFARMA  The Dutch Association of the Innovative \nPharmaceutical Industry   \nNEI National Eye Institute (NIH)   \nNEM Nahrungserg\u00e4nzungsmittel  \nNemV  Nahrungserg\u00e4nzungsmittelverordnung   \nNF  national formulary   \nNfG  Note for Guidance   \nNG  Nachweisgrenze   \nNGO  Non-Governmental Organisation   \nNHI  National Health Insurance (Japan)   \nNHLBI  National Heart, Lung and Blood Institute  NI H \nNHS  National Health Service (UK)   \nNHW  National Health and Welfare Department  Canada   \nNi Nickel  \nNIAID  National Institute of Allergies and Infectio us \nDiseases  USA) \nNICE  National Institute for Health and Clinical \nExcellence   \nNICHD  National Institute of Child Health and Human  \nDevelopment  NIH \nNIDA  National Institute on Drug Abuse   \nNIFDE  National Institute of Food and Drug Safety \nEvaluation  Korean Technical Evaluation \nInstitute  27 \n Short Cut Complete Name  Additional Information  \nNIH  National Institutes of Health (USA)   \nnih  not invented here   \nNIMP  Non-Investigational Medicinal Product   \nNINDS  National Institute of Neurological Disorders  & \nStroke (NIH)   \nNIP  National Institute of Pharmacy   \nNIR  Nah-Infrarot   \nNIS  Nichtinterventionelle Studie   \nNIT  non-interventional trial   \nNITR  National Institute of Toxicological Research  Korea \nNJW  Neue Juristische Wochenschrift   \nnK neue Konzeption  \nNMDA  N-Methyl-D-aspartate   \nNME  New Molecular Entity   \nNMR  nuclear magnetic resonance   \nNMT  not more than that   \nNNH  number needed to harm   \nNNT  number needed to treat   \nNOAEL  non-observed adverse effect level  h\u00f6chste t oxische Dosis, die \nnichts zeigt \nNOC  Notice of Compliance  Canada, India \nNOEC No Observed Effect Concentration  \nNOEL  no observed effect level   \nNRB  Non-institutional Review Board,  also known as  an independent \nreview board. See also EAB, \nIEC, IRB  \nNRC  Nuclear Regulatory Commission   \nNRF  Neues Rezept Formularium   \nNRG  Name Review Group   \nNSAID  non-steroidal anti-inflammatory drug   \nNtA  Notice to Applicants   \nNTP  National Toxicology Program   \nNUB Neue Untersuchungs- und Behandlungs- \nmethoden  \nNUIS Non-Urgent Information System  \nNUMA New Use marketing authorization  \nNvWZ  Neue Zeitschrift f\u00fcr Verwaltungsrecht   \nNW  Nebenwirkungen   \nNwG Notification with grounds  \nNYHA  New York Heart Association (scoring system)   \nNZ  New Zealand   \nNZL  Nachzulassung   \nNZLB  Nachzulassungsbescheid   \nOAI  Official Action Indicated  (serious FDA post-i nspection \nclassification)  \nOC  Operationscharakteristik   \nOC  Oral Contraceptive   \nOCABR Official control authority batch release  \nOCI  Office of Criminal Investigation   \nOCLC  Online Computer Library Center   \nOD  optical disk   28 \n Short Cut Complete Name  Additional Information  \nODE  Office of Drug Evaluation  (CDER now has five such \noffices: ODE I, II, III, IV, and V.)  \nODE Orphan Drug Exclusivity Generics USA \nOE  oral explanation   \nOECD  Organisation for Economic Co-operation and \nDevelopment  (Organisation f\u00fcr wirtschaftliche \nZusammenarbeit und \nEntwicklung) franz.: OCDE \n(organisation de coop\u00e9ration et \nde dev\u00e9loppement \n\u00e9conomiques)  \nOFT  Office of Fair Trading   \nOGD  Office of Generic Drugs  (CDER, formerly DGB)  \nOGE  Office of Government Ethics  (formerly part of  Office of \nPersonnel Management, \nseparate executive branch in \n1989)  \nOHE  Office of Health Economics (U.K.)   \nOHIM  Office for Harmonisation in the Internal \nMarket (Warenzeichen)   \nOHRP Office for Human Research Protection USA \nOIE  International Office of Epizootics  Internatio nales Tierseuchenamt  \nOJC  Office Journal of the EU-C Series \n(Information)   \nOJEC  Official Journal of the European Community   \nOJL  Office Journal of the EU-L Series (Legislation )   \nOLAF  European Anti-Fraud Office   \nOLG  Oberlandesgericht   \nOMB  Office of Management and Budget (USA)   \nOMCL  Official Medicines Control Laboratories  \nOMICS  Sammelbegriff f\u00fcr Spezialdisziplinen aus dem  \nBereich der Biotechnologie mit der Endsilbe \u201e-\nomics\u201c   \nOML  overall migration limit   \nOMOP Observational Medical Outcomes Partnership  \nOMP  Orphan Medicinal Product   \nOOS  out of specification   \nOP  Originalpackung   \nOPPI  Organisation of Pharmaceutical Producers of \nIndia   \nOPRR  Office of Protection from Research Risks  NIH  \nOPS  Operationsschl\u00fcssel nach Paragraph 301 \nSGB V   \nOQ  Operational Qualification   \nORA  Office of Regulatory Affairs   \nORD  Optische Rotationsdispersion   \nOs Osmium  \nOSPAR  Oslo-Paris-Konvention   \nOSHA  Occupational Safety Health Administration USA  \nOTA  Office of Technology Assessment USA; Congress abolished, fall \n1995 \nOTC  over-the-counter, apothekenpflichtig non-presc ription medicines  \nOVG  Oberverwaltungsgericht   29 \n Short Cut Complete Name  Additional Information  \nOwiG  Ordnungswidrigkeitengesetz  German Law on Mis demeanors  \nP-i  parallel-imported   \nPA  Proprietory Association   \nPAD  Pharmacologically Active Dose   \nPAES Post Authorisation Efficacy Studies  \nPAF  platelet activating factor   \nPAG Post /g1uthorization guidance (EMA)  \nPAGB  Proprietary Association of Great Britain   \nPAHO  Pan-American Health Organisation   \nPAI  pre-approval inspection   \nPAP Programmablaufplan   \nPALC Pre-Accession Linguistic Checking  \nPANDRH  Pan American Network for Drug Regulatory \nHarmonization   \nPAR  Public Assessment Report, pain relief   \nPARNUTS  Foods for Particular Nutritional Use   \nPASS  Post Authorisation Safety Study   \nPAT process analytical technology  \nPatG  Patentgesetz   \nPb Blei  \nPBS  Pharmaceutical Benefit Scheme (AUS)   \nPBL  Packungsbeilage   \nPBM  pharmacy benefit management   \nPCA  patient controlled analgesia   \nPCC  Poison Control Centre   \nPCP  Pneumocystis Carnii Pneumonia   \nPCR Polymerase-Kettenreaktion (engl. polymerase \nchain reaction)  \nPCR Preclinical Reviewer  \nPCV  packed cell volume   \nPCWP  Patients\u2019 and Consumers\u2019 Working Party  EMA H uman Scientific \nCommittees Working Party with \nPatients\u2019 and Consumers\u2019 \nOrganisations  \nPd Palladium  \nPD  pharmacodynamics   \nPDCO  Paediatric Committee   \nPDE  permitted daily exposure   \npdf  portable document  format   \nPDG  Pharmacopeial Discussion Group   \nPDQ  Physicians\u2019 Data Query (NCI-sponsored \ncancer trial registry)   \nPDR  Physician Desk Reference   \nPDUFA  Prescription Drug User Fee Act US act for \nfaster review of drug applications   \nPDVE  PIM DES Validation Engine  Siehe auch PIM und  DES  \nPE Polyethylene  \nPEAKPID  peak pain intensity difference   \nPEC  Predicted Environmental Concentration   \nPEFRAS  Pan-European Federation of Regulatory \nAffairs Societies   30 \n Short Cut Complete Name  Additional Information  \nPEI  Paul-Ehrlich-Institut  Bundesinstitut f\u00fcr Impf stoffe und \nbiomedizinische Arzneimittel, \nDeutschland \nPEM  Prescription Event Monitoring (UK)   \nPER scheme  Pharmaceutical Evaluation Report Scheme  \nfor mutual recognition of evaluation reports   \nPERI  Pharmaceutical Education & Research \nInstitute   \nPET  positron emission tomography   \nPET Polyethylene Terephthalate  \nPfSchG  Pflanzenschutzgesetz   \nPFT  pulmonary function tests  \n  \nPGP  pretty good privacy  Verschl\u00fcsselungssoftware  \nPHA  preliminary hazard analysis   \nPharmBetr.V  Pharmazeutische Betrieb-Verordnung  wu rde durch die AMWHV \nersetzt  \nPHI  Private Health Insurance   \nPh.Eur.  European Pharmacopoeia   \nPh. Helv.  Pharmacopoeia Helvetica Arzneibuch der \nSchweiz   \nPhRMA  Pharmaceutical Research and Manufacturers \nof America   \nPHS  Public Health Service   \nPh.U.  Pharmazeutischer Unternehmer  auch: PU  \nPhV  Pharmakovigilanz   \nPhVWP  Pharmacovigilance Working Party   \nPI  principle investigator   \nPI  parallel Import/Importeur   \nPI  package insert   \nPI Produktinformation (FI + GI)  \nPI Product Information (SPC, PIL, labeling)  \nPIA  Pre-Approval Inspections (USA)   \nPIC  Pharmaceutical Inspection Convention   \nPICO Hilfsschema f\u00fcr die Formulierung einer \nklinischen Frage zur Wirkung von \nInterventionen: \npatient, intervention, Vergleichsintervention \n(comparison), Zielgr\u00f6sse ( outcome)  relevant bei der \nNutzenbewertung von AM \nPIC Site Master File  Explanatory notes for industr y on the \npreparation of a Site Master File guidelines for GMP  \nPIC-S  PIC-Scheme   \nPID  pain intensity difference   \nPID  pelvic inflammatory disease   \nPIF products information form   \nPIL = PL  patient information leaflet   \nPIM  Product Information Management   \nPIP  Paediatric Investigation Plan   \nPK  pharmacokinetics   \nPK  Produktkonferenz   \nPKV  Private Krankenversicherung   \nPL  package leaflet  Packungsbeilage 31 \n Short Cut Complete Name  Additional Information  \nPL(PI)  Product License for Parallel Imports   \nPLA  Product Licence Application (biological in the  \nUS)   \nPLATO Pl\u00e4ttchenhemmung und Patienten-Outcomes \n(PLATO) Studie  \nPLUS  Product Licence User System   \nPMA  Pharmaceutical Manufacturers Association  now PhRMA \nPMA  Premarket approval application  FDA \nPMDA Pharmaceuticals and Medical Device \nEvaluation Center  japan. Zulassungsbeh\u00f6rde \nPMF  Plant Master File (US); Plasma Master \nFile(EU)   \nPMQR Pre-Migration Quality Review  \nPMS  post-marketing surveillance   \nPMS  Paul-Martin-Stiftung   \nPNEC  predicted no effect concentration   \nPNR  Pharmazeutischer Unternehmer-Nummer des \nBfArM   \nPoC Proof of Concept  \nPOM  prescription only medicines   \nPP Polypropylene  \nPPA  potential problem analysis  Modul 12, Unterlag en Herr Jopp \nPPB  plasma products biotechnology   \nPPI  producer price index   \nPPI proton pump inhibitor   \nPPI patient package insert   \nPPID  peak pain intensity difference   \nPPO  Preferred Provider Organization; Policy and \nProcedure Order   \nPPP  Pregnancy Prevention Program  \nPPPA Poison Prevention Packaging Act  \nPPRS  Pharmaceutical Price Regulation Scheme  UK \nPPSB  Prothrombinkonzentrat Blutprodukt, in dem bes timmte \nVitamin-K-abh\u00e4ngige \nGerinnungsfaktoren konzentriert \nsind \nPPSR Proposed Pediatric Study Request  \nPQ  performance qualification   \nPQR  product quality review   \nPR  Public Relations   \nPR pain relief  \nPRAC Pharmacovigilance Risk Assessment \nCommittee  \nPREA  Pediatric Research Equity Act USA \nPRIMR Public Responsibility in Medicine and \nResearch  (Boston, MA)  \nP-RMS PSUR Reference Member State  \nPRS PIM Review System  \nPSC  Pharmaceutical Committee  Unterkommitee von AD EC  \nPSD Particle size distribution  \nPSMF Pharmacovigilance System Master File  \nPSP Paediatric Study Plan  32 \n Short Cut Complete Name  Additional Information  \nPSRPH  Potential Serious Risk to Public Health   \nPSU/PSUR  Periodic Safety Update Report   \nPt Platin  \nPTA  Percutaneous Transluminal Angioplasty   \nPTB  Physikalisch-Technische Bundesanstalt   \nptc points to consider   \nPTCA  Percutaneous Transluminal Coronary \nAngioplasty   \nPTE Patent Term Extension  \nPTF Peak Trough Flukt.  \nPTH  Parathormon   \nPTL  Product Team Leader EMA Product Team   \nPTM  Products Team Member EMA Product Team   \nPTP  Previously Treated Patients   \nPTS  proficiency testing study  \nPU  Pharmazeutischer Unternehmer  auch: Ph.U. \nPUD  peptic ulcer disease   \nPUMA  Paediatric Use Marketing Authorisation   \nPUP  previously untreated patients   \nPV Pharmacovigilance  \nPVA Polyvinyl Alcohol  \nPVAR Preliminary Variation and Assessment Report  \nPVC Polyvinyl Chloride  \nPVP  polyvinylpyrollidone   \nPZ  Pharmazeutische Zeitung   \nPZN  Pharmazentralnummer   \nPZU  Postzustellungsurkunde   \nQA  Quality Assurance   \nQALY  Quality Adjusted Life Year  qualit\u00e4tsadjustie rtes Lebensjahr \nQOS  Quality Overall Summary   \nQALY quality-adjusted life year  \nQAU  Quality Assurance Unit   \nQbD Quality by Design  \nQBR  question-based review   \nQC  quality control concerned with sampling, \nspecifications, testing and \ndocumentation and release \nprocedures  \nQCO  Quality Control Organization   \nQM  Quality Management   \nQM Maximum Quantity Max. allowed monomeric \nresidue in plastic compnents \nQMS  Quality Management System   \nQL / QOL  quality of life   \nQP  Qualified Person   \nQPPV  Qualified Person for Pharmacovigilance   \nQR Quality Reviewer  \nQRD  Quality Review of Documents   \nQS  Qualit\u00e4tssicherung   \nQT-interval  QT-Zeit  (gesamte intraventrikul\u00e4re \nErregungsdauer)  33 \n Short Cut Complete Name  Additional Information  \nQTPP Quality Target Product Profile  \nQWP  Quality Working Party   \nR & D  Research and Development  Forschung und Entw icklung \nR&TD  Research and Technological Development   \nRA  Rheumatoid Arthritis   \nRAD-AR  Risk-Benefit Assessment of Drugs-Analysis \nand Response   \nRAM  Regulatory Affairs Manager   \nRAPS  Regulatory Affairs Professionals Society   \nRAS  rapid alert system   \nRBC  red blood cell  rotes Blutk\u00f6rperchen \nRCP  Royal College of Physicians (London, UK)   \nRCT  randomized clinical trial   \nRDA  recommended daily allowances   \nRDE  remote data entry   \nRDP  Regulatory Data Protection   \nRDRC  Radioactive Drug Research Committee   \nREA relative effectiveness assessment  \nREACh  Registration, Evaluation and Authorisation o f \nChemicals   \nReg.  Regulation   \nReg. Nr.  Registrierungsnummer   \nREMS Risk Evaluation and mitigation strategy  \nRFD  request for designation   \nRh Rhodium  \nRHA  Regional Health Authorities   \nRIA  Radioimmunpr\u00e4zipitation   \nRiliB\u00c4K  Richtlinie der Bundes\u00e4rztekammer zur \nQualit\u00e4tssicherung quantitativer \nlaboratoriumsmedizinischer Untersuchungen \nrINN recommended International \nNonproprietary Name   \nRINGs Regulatory Intelligence Network Groups  \nRKI  Robert-Koch-Institut   \nRL  Regulatory Letter  (FDA post-audit letter)  \nRL  Richtlinie   \nRMP  Risk Management Plan   \nRMS  Reference Member State, Member state \nwhich issued the first marketing authorization \nin the EU  (base of a MRP)  \nrm TD  rechnerische mittlere Tagesdosis   \nRPM Regulatory Project Manager (USA)  \nRPS Regulated Product Submission  \nRQ Risk quotient  \nRQA  Research Quality Assurance   \nRRR  Relative Risk Reduction   \nRSA Risikostrukturausgleich Modul 11 \nRSI Request for Supplementary Information  \nRTF  refuse/refusal to file  Ablehnender Bescheid d er FDA  \nRTR real-time release  \nRTRT real-time release testing  34 \n Short Cut Complete Name  Additional Information  \nRx  prescription only medicines  Verschreibungspfli chtiges \nMedikament  \nSA  scientific advice   \nSA  situation appraisal Modul 12, Unterlagen Herr J opp  \nSAA  Standard-Arbeits-Anweisung   \nSADC Southern African Development Community   \nSADR  serious adverse drug reaction   \nSAE  serious adverse event   \nSAG  Scientific Advisory Group EMA   \nSAMM  Guidelines for Company Sponsored Safety \nAssessment of Marketed Medicines  (UK)  \nSAR  structure activity relationship   \nSAS  statistical analysis system   \nSAWP  Scientific Advice Working Party   \nSBA  Summary Basis of Approval  USA, now: New Drug Approval \nPackage  \nSBD  Summary Basis of Decision Kanada   \nSC  Study Coordinator. See also CCRC, CRC.   \nSCI  spinal cord injury   \nSCM  Suppy Change Management   \nSCT  Society for Clinical Trials   \nSD  source data / source document   \nSD  single dose   \nSD  standard deviation   \nSDH Sorbitol Dehydrogenase  \nSDAT  Senile Dementia of the Alzheimer\u2019s Type   \nSDO  Standard Development Organization   \nSDV  Source Data Verification   \nSE  standard error   \nS/E-Pre  Safety and efficacy, pre-authorisation   \nSEA  Single European Act of 1987   \nSEC  Stock Exchange Commission   \nSEC Size-exclusion chromatography  \nSEDAMM  Submissions Electronique de Dossiers \nd\u2019France de Mise sur le Marche   \nSEER  Surveillance, Epidemiology, and End Results \n(Registry of NCI)   \nSESAR Suspected Expected Serious Adverse \nReaction   \nSEQ Safety, Efficacy, Quality  \nSF safety factor   \nSF Senior friendly Siehe auch CR \nSFC Supercritical fluid chromatography  \nSFDA  State Food and Drug Administration Chin. Zula ssungsbeh\u00f6rde  \nSGB  Sozialgesetzbuch   \nSGB V  Sozialgesetzbuch, F\u00fcnftes Buch   \nSGML  Standard Generalised Mark-up Language   \nSH Subject Heading  \nSHR   \nSI  Syst\u00e8me International d\u2019Unit\u00e9s   \nSIAMED  Model System for Computer-assisted Drug WHO   35 \n Short Cut Complete Name  Additional Information  \nRegistration  \nSIAR  Societ\u00e0 Italiana Attivit\u00e0 Registrativa   \nSICA Sistema de la Integraci\u00f3n Centroamericana Zent ralamerikanisches \nIntegrationssystem \nSIDA  The Spanish (syndrome inmunodeficiencia \nadquirida), Italian and French abbreviation for \nAIDS: see AIDS.   \nSKNR  Strukturnummer  Vierstellige Nummer  \nSL-List List of Pharmaceutical Specialities (Schwei z) \nSM  Selbstmedikation  (s.OTC)  \nSMART  Submission Management and Review \nTracking (FDA)  \nSMDA  Safe Medical Devices Act  (1990)  \nSME  Significant Medical Event   \nSME  small and medium enterprises   \nSMEC Swissmedic Medicines Expert Committees (Schwei z) \nSMF  Site Master File   \nSML  specific migration limit   \nSMOP  summary of opinion   \nSmPC  Summary of Product Characteristics   \nSNIP  Syndicat National de l\u2019Industrie \nPharmaceutique  (France)  \nSAOD  Scientific Advice and Orphan Drugs Sector \nEMA   \nSOMED  Datenbank der Sozialmedizin   \nSOP  Standard Operating Procedure   \nSPA Special Protocol Assessment  binding advice in US  \nSPC  Supplementary Protection Certificate  Extensio n of the period of patent \nprotection in the EU \nSPC (SmPC)  Summary of Product Characteristics  Cor responds to the German \nFachinformation  \nSpec Specification  \nSPID  sum of pain intensity difference   \nSPIDt  sum of pain intensity difference over time   \nSPOC  Single Point of Contact EDQM   \nSPOR Substance, Product, Organisation, Referential   \nSPS  Summary of Pharmacovigilance System   \nSRA  Scientific Research Associates   \nSRS  Sleep Research Society   \nSSC Sunset Clause  \nSSI Structured Substance Information  \nSSL  secure sockets layer   \nSSM  skin surface microscopy   \nSSRA  Swedish Society of Regulatory Affairs   \nSST  System Suitability Test  (Systemeignungstest)  \nSTD  sexually transmitted disease   \nSTD Severely Toxic Dose  \nSTE Surrogate Threshold Effect  \nStGB  Strafgesetzbuch   \nSTIKO  St\u00e4ndige Impfkommission  (des Robert-Koch-In stituts \n(RKI))  36 \n Short Cut Complete Name  Additional Information  \nSTP  sewage treatment plant   \nSTR  Scientific Technical and Regulatory   \nSTS  standard toxicity study   \nSTT  short term tests   \nSUD  Sudden Unexpected Death   \nSUPAC  Scale-up and Post Approval Changes   \nSUSAR  Suspected Unexpected Serious Adverse \nReaction   \nSVR sustained virologic response dauerhaftes virolo gisches \nAnsprechen \nSWEDIS  A computer system used by the Swedish \nMPA   \nSWISSMEDIC Swiss Agency for Therapeutic Products Sc hweizerisches \nHeilmittelinstitut \nSWP  Safety Working Party   \nt \u00bd  half life time   \nTAM Tierarzneimittel  \nTCM  Traditionelle Chinesische Medizin Traditional \nChinese Medicine   \nTCP  Transmission Control Protocol Protokoll in der  \nInformationstechnik   \nTDAR  T-cell Dependent Antibody Response   \nTDI  Total Daily Intake   \nTE Therapeutice Equivalence  \nTEP Tissue Engineered Products  \nTF  Tabular Formats   \nTGA  Therapeutic Goods Authority  Regulatory author ity in Australia  \nTGD  Technical Guidance Document   \nTIGes Telematics Implememtation Group  \nTHMP  Traditional Herbal Medicinal Product   \nTIND  Treatment IND See also IND.  \nTIVA  totale intraven\u00f6se Anaesthesie   \nTK  toxicokinetics   \nTKM  toxicokinetic measurements   \nTLC  Thin Layer Chromatography   \ntmax  Zeitpunkt der maximalen \nPlasmakonzentration   \nTMF  Trial Master File   \nT (O)  Plasma concentration at time zero   \nTOC  Total Organic Carbon Gesamter organischer \nKohlenstoff   \nTOC Table of Contents  \nTOPRA  The Organisation for Pharmaceutical \nRegulatory Affairs   \nTOTPAR total pain relief   \nTPA  tissue plasminogen activator   \nTPD  Therapeutic Products Directorate  B\u00fcro innerha lb der kanadischen \nHPFB, zust\u00e4ndig f\u00fcr die \nArzneimittelzulassung  \nTPM  third party manufacturer   \nTQM  Total Quality Management   \nTRGS  technische Regeln f\u00fcr Gefahrstoffe zur  37 \n Short Cut Complete Name  Additional Information  \nGefahrstoffverordnung  \nTRIPS  Trade-Related Aspects of Intellectual \nProperty Rights   \nTSC  Telematics Steering Committee   \nTSD  target standard deviation  (Zielstandardabweic hung)  \nTSH  Thyroidea-stimulierendes Hormon   \nTTC  Treshold of Toxicological Concern   \nTUR traditional use registration  \nUAW  Unerw\u00fcnschte Arzneimittelwirkung   \nUDP- Uridine 5'-diphospho- Siehe: UGT \nUDS  unplanm\u00e4\u00dfige DANN-Synthese   \nUE  Unerw\u00fcnschtes Ereignis   \nUGT UDP-Glucuronosyltransferase Siehe: UDP \nUKCCR  UK Coordinating Committee on Cancer \nResearch   \nUM  Unverk\u00e4ufliches Muster   \nUMC  Uppsala Monitoring Center   \nUMDNS  Universal Medical Device Nomenclature \nSystem   \nUMLS  Unified Medical Language System   \nUNESCO  United Nations Educational, Scientific and \nCultural Organisation   \nUNAIDS  Gemeinsames Programm der Vereinten \nNationen f\u00fcr HIV/Aids   \nUNDCP  United Nations Drug Control Programme   \nUNII Unique Ingredient Identifiers  \nUNODC  United Nations Office on Drugs and Crime   \nURL  Uniform Resource Locator   \nUSAN USP  Dictionary of US Adopted Names and \nInternational Drug Names   \nUSC  United States Code  (book of laws)  \nUSDA  United States Department of Agriculture   \nUSL  upper specification limit   \nUSP  United States Pharmacopeia  Amerikanisches Arz neibuch  \nUSP  unique selling position  Marketing term  \nUSPTO  US Patent & Trademark Office   \nUSR Urgent Safety Restriction  \nUT Uncontrolled Terms  \nUTI  urinary tract infection   \nUTN  Universal Trial Number   \nUV  Ultraviolettspektroskopie   \nV Vanadium  \nVA  Verl\u00e4ngerungsantrag   \nVA  Veterans Administration  (officially, United St ates \nDepartment of Veterans Affairs)  \nVAI  Voluntary Action Indicated  (FDA post-audit in spection \nclassification)  \nVAMF  Vaccine Antigen Master File   \nVAS  Visual analogue scale   \nVAR Variation Assessment Report  \nVB  Verl\u00e4ngerungsbescheid   38 \n Short Cut Complete Name  Additional Information  \nVCJD  Variant Creutzfeldt-Jakob Disease   \nVEDDRA Veterinary Dictionary for Drug Related Affai rs  \nvfa  Verband forschender Arzneimittelhersteller   \nVHP Voluntary Harmonisation Procedure  \nVICH  Veterinary International Conference on \nHarmonisation of Technical Requirements for \nRegistration of Pharmaceuticals for \nVeterinary Use   \nVMEC Veterinary Medicines Expert Committee (Schweiz ) \nVMP  Veterinary Medicinal Product   \nVMRF  Veterinary Mutual Recognition Facilitation \nGroup   \nVO  Verordnung   \nVOI analysis value of information analysis  \nVohA  Verordnung \u00fcber hom\u00f6opathische \nArzneimittel   \nVPN  virtual private network  \nVRS verbal rating scale   \nvs  versus   \nVSV  vescicul\u00e4rer stomatis virus   \nVU  Verunreinigung   \nvWF  von Willebrand Faktor   \nVwGO  Verwaltungsgerichtsordnung   \nVWP  Vaccine Working Party Expertenfachgruppe \nbei der EMA   \nVwV  Verwaltungsvorschrift  (German Administrative \nProcedure)  \nVwVfG  Verwaltungsverfahrensgesetz   \nWBC  white blood cell   \nWCO  World Customs Organization  Internationale Org anisation mit \nSitz in Br\u00fcssel (Belgien), die \nsich darauf spezialisiert hat, die \nZollformalit\u00e4ten zwischen den \ninternationalen Handelspartnern \nzu vereinfachen.  \nWE Wareneingang  \nWEU  well-established use   \nWGEO  Working Group of Enforcement Officers by \nHeads of Medicines Agensies (HMA)   \nWGQM  Working Group QM   \nWHA  World Health Assembly   \nWHO  World Health Organization \n(Weltgesundheitsorganisation)   \nWHOART  World Health Organization Adverse Reaction \nTerminology   \nWHO-ECDD Expert Committee on Drug Dependence UN: Sa chverst\u00e4ndigen-\nausschuss \nWI Working Instructions  \nWIDO  Wissenschaftliches Institut der \nOrtskrankenkassen   \nWIPO  World Intellectual Property Organization  Tei lorganisation der UN  \nWL  Warning Letter (most serious FDA post-audit 39 \n Short Cut Complete Name  Additional Information  \nletter, demands immediate \naction within 15 days)  \nWMA World Medical Association Welt\u00e4rztebund \nWOCP  Worldwide Organization for Collaborations in \nthe Pharmaceutical Industry   \nwP whole-cell pertussis pertussis vaccines \nWP  Working Party   \nWS Worksharing  \nWSMI  World Self Medication Industry   \nWSP Worksharing Project  \nWTO  World Trade Organization   \nWVFR Water Vapor Transmission Rate  \nWW Wechselwirkungen  \nWWW  World Wide Web   \nXCOMP Eudra Vigilance External Compliance  Eudra Vi gilance External \nCompliance (XCOMP) Testing \nEnvironment \n(X)EVMPD (Extended) Eudra Vigilance Medicinal \nProduct Dictionary  \n(X)EVPRM (Extended) Eudra Vigilance Medicinal \nProduct Report Message  \nXML  Extensible Markup Language   \nXPA  Xeroderma pigmentosum group A   \nZEBET  Zentrale Erfassungs-und Bewertungsstelle f\u00fcr  \nErsatz-und Erg\u00e4nzungsmethoden zum \nTierversuch   \nZLG  Zentralstelle der L\u00e4nder f\u00fcr \nGesundheitsschutz bei Arzneimitteln und \nMedizinprodukten   \nZLS  Zentralstelle der L\u00e4nder f\u00fcr \nSicherheitstechnik   \nZn Zink  \nZKA  Zollkriminalamt   \nZKBS  Zentrale Kommission f\u00fcr Biologische \nSicherheit  (D) \nZQ  Zentralstelle f\u00fcr Qualit\u00e4tssicherung   \nZul. Nr.  Zulassungsnummer   \nZZulV Zusatzstoff-Zulassungsverordnung   \n ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}